Skip Navigation

Brain 2005 128(9):1962-1963; doi:10.1093/brain/awh611
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Munoz, D. G.
Right arrow Articles by Woulfe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munoz, D. G.
Right arrow Articles by Woulfe, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Scientific Commentary

Semantic dementia: linking loss of brain and brawn

The first 10% of the full text of this article appears below.

The term frontotemporal dementia (FTD) refers to a closely related group of conditions characterized by slowly progressive selective deficits of behavioural, verbal, and/or motor functions, sparing other higher neural activities. The two best characterized syndromes are (i) behavioural disturbances that correspond to the pattern recognized by clinicians as frontal dementia, and (ii) a non-fluent progressive aphasia. Pathological examination shows neuronal death restricted to specific areas, leading to severe atrophy mostly restricted to frontal and temporal regions, contrasting with well preserved neighbouring gyri. In almost all cases, affected neurons display peculiar inclusion bodies of a finite number of varieties, the morphology and staining properties of which dictate pathological classification of FTD. Approximately 40–50% of FTD cases express the microtubule associated protein tau in the inclusion bodies (tau+), and are . . . [Full Text of this Article]

David G. Munoz1, Teodoro Del Ser2 and John Woulfe3

1 University of Toronto and St. Michael's Hospital, Toronto, Canada 2 Neuropharma, Madrid, Spain 3 University of Ottawa and Ottawa Health Research Institute, Ottawa, Canada

E-mail: dave_munoz@yahoo.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?